Table 4.
Etiological agents of VAP and antibacterial resistance pattern.
| Pathogens | Antibiotic Resistance Pattern (% of Resistance) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMX | AMC | TIC | TCC | PIP | TZP | CAZ | IMP | GEN | AM | NET | CST | CIP | FOS | RIF | |
| A. baumannii (n = 32) | - | - | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 85 | 26 | 0 | 100 | 85 | 60 |
| P. aeruginosa (n = 22) | - | - | 77 | 55 | 44 | 0 | 67 | 44 | 77 | 11 | 0 | 0 | 48 | 11 | - |
| Enterobacterales (n = 17) | 100 | 71 | 100 | 71 | 100 | 71 | 71 | 0 | 28 | 14 | 28 | - | 14 | - | - |
AMX: amoxicillin; AMC: amoxicillin–clavulanic acid, TIC: ticarcillin, TCC: ticarcillin–clavulanic acid, PIP: piperacillin, TZP: pipercillin–tazobactam, CAZ: ceftazidime, IMP: imipenem, GEN: gentamicin, AM: amikacin, NET: netilmycin, CST: colistin, CIP: ciprofloxacin, FOS: fosfomycin, RIF: rifampin; -: not tested.